{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:13:52Z","timestamp":1767651232497,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T00:00:00Z","timestamp":1464825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T00:00:00Z","timestamp":1464825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R34DA035094"],"award-info":[{"award-number":["R34DA035094"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13011-016-0065-2","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T03:57:07Z","timestamp":1464839827000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Drug preparation, injection, and sharing practices in Tajikistan: a qualitative study in Kulob and Khorog"],"prefix":"10.1186","volume":"11","author":[{"given":"David","family":"Otiashvili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alisher","family":"Latypov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irma","family":"Kirtadze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umedjon","family":"Ibragimov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Zule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,2]]},"reference":[{"issue":"7","key":"65_CR1","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1080\/17441692.2015.1043313","volume":"10","author":"S Ancker","year":"2015","unstructured":"Ancker S, Rechel B. Policy responses to HIV\/AIDS in Central Asia. Glob Public Health. 2015;10(7):817\u201333.","journal-title":"Glob Public Health"},{"issue":"2","key":"65_CR2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s11904-014-0202-3","volume":"11","author":"J DeHovitz","year":"2014","unstructured":"DeHovitz J, Uuskula A, El-Bassel N. The HIV epidemic in Eastern Europe and Central Asia. Curr HIV\/AIDS Rep. 2014;11(2):168\u201376.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"6","key":"65_CR3","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.drugpo.2014.09.011","volume":"25","author":"A Latypov","year":"2014","unstructured":"Latypov A, Otiashvili D, Zule W. Drug scene, drug use and drug-related health consequences and responses in Kulob and Khorog, Tajikistan. Int J Drug Policy. 2014;25(6):1204\u201314.","journal-title":"Int J Drug Policy"},{"key":"65_CR4","volume-title":"UNAIDS country progress report","author":"Ministry of Health of Republic of Tajikistan","year":"2015","unstructured":"Ministry of Health of Republic of Tajikistan. UNAIDS country progress report. Dushanbe: Ministry of Health of Republic of Tajikistan; 2015."},{"key":"65_CR5","volume-title":"Report on the results of bio-behavioral surveliance survey among people who inject drugs in Republic of Tajikistan in 2014","author":"Ministry of Health of Republic of Tajikistan","year":"2015","unstructured":"Ministry of Health of Republic of Tajikistan. Report on the results of bio-behavioral surveliance survey among people who inject drugs in Republic of Tajikistan in 2014. 2015."},{"key":"65_CR6","volume-title":"Drug situation in the Republic of Tajikistan in 2014","author":"Drug Control Agency under the President of Republic of Tajikistan","year":"2015","unstructured":"Drug Control Agency under the President of Republic of Tajikistan. Drug situation in the Republic of Tajikistan in 2014. 2015."},{"key":"65_CR7","unstructured":"World Bank. New Country Classifications 2015. Available from: \n                    http:\/\/data.worldbank.org\/news\/new-country-classifications-2015\n                    \n                  . Accessed 15 Aug 2015."},{"key":"65_CR8","unstructured":"Tukeyev M, Ganina L, Yelizarieva A, Petrenko I, Balabayev T, Kudusova E, et al. 2006\u20132010 Kazakhstan National AIDS Programme Progress Report. Astana: Ministry of Health of the Republic of Kazakhstan. 2011."},{"key":"65_CR9","volume-title":"Modelling an optimised investment approach for Tajikistan","author":"Ministry of Health of Republic of Tajikistan","year":"2014","unstructured":"Ministry of Health of Republic of Tajikistan, UNDP. Modelling an optimised investment approach for Tajikistan. Dushanbe: UNDP; 2014."},{"issue":"1","key":"65_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drugpo.2013.07.001","volume":"25","author":"GJ MacArthur","year":"2014","unstructured":"MacArthur GJ, van Velzen E, Palmateer N, Kimber J, Pharris A, Hope V, et al. Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. Int J Drug Policy. 2014;25(1):34\u201352.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"65_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/jvh.12117","volume":"21","author":"N Palmateer","year":"2014","unstructured":"Palmateer N, Hutchinson S, McAllister G, Munro A, Cameron S, Goldberg D, et al. Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data. J Viral Hepat. 2014;21(1):25\u201332.","journal-title":"J Viral Hepat"},{"issue":"1","key":"65_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10461-005-1679-y","volume":"9","author":"S Koester","year":"2005","unstructured":"Koester S, Glanz J, Baron A. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. AIDS Behav. 2005;9(1):27\u201339.","journal-title":"AIDS Behav"},{"key":"65_CR13","doi-asserted-by":"crossref","unstructured":"Rhodes T, Mikhailova L, Sarang A, Lowndes CM, Rylkov A, Khutorskoy M. Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment. Soc Sci Med. 2003;57(1):39\u201354.","DOI":"10.1016\/S0277-9536(02)00521-X"},{"issue":"3","key":"65_CR14","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1465-3362.2009.00142.x","volume":"29","author":"L Wilkins","year":"2010","unstructured":"Wilkins L, Bissell P, Meier PS. Risky injecting practices associated with snowballing: a qualitative study. Drug Alcohol Rev. 2010;29(3):256\u201362.","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"65_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-015-1404-3","volume":"15","author":"T Ahmed","year":"2015","unstructured":"Ahmed T, Long TN, Huong PT, Stewart DE. Drug injecting and HIV risk among injecting drug users in Hai Phong, Vietnam: a qualitative analysis. BMC Public Health. 2015;15(1):1\u201313.","journal-title":"BMC Public Health"},{"issue":"9","key":"65_CR16","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3109\/10826084.2011.552932","volume":"46","author":"E Roy","year":"2011","unstructured":"Roy E, Arruda N, Bourgois P. The growing popularity of prescription opioid injection in downtown Montreal: new challenges for harm reduction. Subst Use Misuse. 2011;46(9):1142\u201350.","journal-title":"Subst Use Misuse"},{"issue":"6","key":"65_CR17","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/j.1360-0443.2011.03765.x","volume":"107","author":"ER Pouget","year":"2012","unstructured":"Pouget ER, Hagan H, Des Jarlais DC. Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment. Addiction (Abingdon, England). 2012;107(6):1057\u201365.","journal-title":"Addiction (Abingdon, England)"},{"issue":"3","key":"65_CR18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF03405004","volume":"93","author":"LA Jackson","year":"2002","unstructured":"Jackson LA, Bailey DL, Fraser JR, Johnson JK, Currie A, Babineau DD. Safer and unsafe injection drug use and sex practices among injection drug users in Halifax, Nova Scotia. An exploratory look at community and interpersonal influences. Can J Public Health. 2002;93(3):219\u201322.","journal-title":"Can J Public Health"},{"issue":"4","key":"65_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1365-2893.2007.00942.x","volume":"15","author":"P De","year":"2008","unstructured":"De P, Roy \u00c9, Boivin JF, Cox J, Morissette C. Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review. J Viral Hepat. 2008;15(4):279\u201392.","journal-title":"J Viral Hepat"},{"key":"65_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12954-016-0099-9","volume":"13","author":"R Abadie","year":"2016","unstructured":"Abadie R, Welch-Lazoritz M, Gelpi-Acosta C, Reyes JC, Dombrowski K. Understanding differences in HIV\/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto Rico. Harm Reduct J. 2016;13:10.","journal-title":"Harm Reduct J"},{"issue":"3","key":"65_CR21","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.socscimed.2004.12.030","volume":"61","author":"H Cooper","year":"2005","unstructured":"Cooper H, Moore L, Gruskin S, Krieger N. The impact of a police drug crackdown on drug injectors\u2019 ability to practice harm reduction: a qualitative study. Soc Sci Med. 2005;61(3):673\u201384.","journal-title":"Soc Sci Med"},{"key":"65_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1471-2458-9-98","volume":"9","author":"DC Thanh","year":"2009","unstructured":"Thanh DC, Moland KM, Fylkesnes K. The context of HIV risk behaviours among HIV-positive injection drug users in Viet Nam: Moving toward effective harm reduction. BMC Public Health. 2009;9:98.","journal-title":"BMC Public Health"},{"issue":"2","key":"65_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/02791072.2013.785811","volume":"45","author":"KM Johnson","year":"2013","unstructured":"Johnson KM, Fibbi M, Langer D, Silva K, Lankenau SE. Prescription drug misuse and risk behaviors among young injection drug users. J Psychoactive Drugs. 2013;45(2):112\u201321.","journal-title":"J Psychoactive Drugs"},{"issue":"5","key":"65_CR24","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/0277-9536(95)00193-X","volume":"42","author":"JP Grund","year":"1996","unstructured":"Grund JP, Friedman SR, Stern LS, Jose B, Neaigus A, Curtis R, et al. Syringe-mediated drug sharing among injecting drug users: patterns, social context and implications for transmission of blood-borne pathogens. Soc Sci Med. 1996;42(5):691\u2013703.","journal-title":"Soc Sci Med"},{"key":"65_CR25","volume-title":"Technical Guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users","author":"WHO","year":"2009","unstructured":"WHO, UNODC, UNAIDS. Technical Guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. 2009."},{"issue":"9","key":"65_CR26","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1007\/s10461-013-0593-y","volume":"17","author":"AS Abdul-Quader","year":"2013","unstructured":"Abdul-Quader AS, Feelemyer J, Modi S, Stein ES, Briceno A, Semaan S, et al. Effectiveness of structural-level needle\/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review. AIDS Behav. 2013;17(9):2878\u201392.","journal-title":"AIDS Behav"},{"key":"65_CR27","first-page":"115","volume-title":"Harm reduction among injecting drug users - evidence of effectiveness. Harm reduction: evidence, impacts and challenges","author":"J Kimber","year":"2010","unstructured":"Kimber J, Palmateer N, Hutchinson J, Hickman M, Goldberg D, Rhodes T. Harm reduction among injecting drug users - evidence of effectiveness. Harm reduction: evidence, impacts and challenges. Lisbon: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA); 2010. p. 115\u201363."},{"issue":"11","key":"65_CR28","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1111\/j.1360-0443.2011.03515.x","volume":"106","author":"KME Turner","year":"2011","unstructured":"Turner KME, Hutchinson S, Vickerman P, Hope V, Craine N, Palmateer N, et al. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction. 2011;106(11):1978\u201388.","journal-title":"Addiction"},{"key":"65_CR29","volume-title":"A review of the effectiveness and cost-effectiveness of needle and syringe programmes for injecting drug users","author":"L Jones","year":"2008","unstructured":"Jones L, Pickering L, Sumnall H, McVeigh J, Bellis M. A review of the effectiveness and cost-effectiveness of needle and syringe programmes for injecting drug users. Liverpool John Moores University: Centre for Public Health; 2008."},{"issue":"10","key":"65_CR30","doi-asserted-by":"publisher","first-page":"e77038","DOI":"10.1371\/journal.pone.0077038","volume":"8","author":"C McGowan","year":"2013","unstructured":"McGowan C, Harris M, Rhodes T. Hepatitis C avoidance in injection drug users: a typology of possible protective practices. PLoS One. 2013;8(10):e77038.","journal-title":"PLoS One"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-016-0065-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13011-016-0065-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-016-0065-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-016-0065-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T11:43:02Z","timestamp":1589542982000},"score":1,"resource":{"primary":{"URL":"https:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/s13011-016-0065-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,2]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["65"],"URL":"https:\/\/doi.org\/10.1186\/s13011-016-0065-2","relation":{},"ISSN":["1747-597X"],"issn-type":[{"type":"electronic","value":"1747-597X"}],"subject":[],"published":{"date-parts":[[2016,6,2]]},"assertion":[{"value":"25 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"21"}}